Model
Edge
Alnylam Pharmaceuticals, Inc.
0001585018
Filing Type
4
Filing Date
10/2/2024
Updated
10/3/24, 2:11 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership